Company / Assets per Share
Vir Biotechnology, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.32
FY2025
5-year range
$7.32 / $21.36
FY2021-FY2025
Trend
-29.4%
vs FY2024
Sector context
#123 of 210
Health Care
What the data says
At $7.32, Vir Biotechnology, Inc.'s assets per share ranks #123 of 210 in the Health Care sector. Assets per Share has declined for 3 consecutive years, from $21.36 in FY2022 to $7.32 in FY2025.
Based on SEC 10-K filings.
7.32 in FY2025 with a 5-year CAGR of -3.0%.
Declined from $14.40 to $7.32 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.0%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
#123 of 210 in Health CareTop 59% of 210This company $7.32 Sector average $353.15
▼
-97.9% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 29.4% year-over-year.
- Ranks #123 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.32 | -29.4% |
| FY2024 | $10.38 | -27.9% |
| FY2023 | $14.40 | -32.6% |
| FY2022 | $21.36 | +39.3% |
| FY2021 | $15.34 | +79.7% |
| FY2020 | $8.53 | -85.2% |
| FY2019 | $57.80 | +131.3% |
| FY2018 | $24.99 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026